A Multi-center, Randomized, Double-blinded Equivalence Clinical Trial to Evaluate Efficacy and Safety of LipiLou 20 mg Versus Lipitor 20 mg in Hypercholesterolemic Patients With Higher Risk Cardiovascular Disease in Korea (KoLipilou)

NCT01029522 Phase 4 COMPLETED

A multi-center, randomized, double-blinded equivalence clinical trial to evaluate efficacy and safety of LipiLou 20 mg versus Lipitor 20 mg in hypercholesterolemic patients with higher risk cardiovascular disease in Korea.

Details

Lead sponsor	Chong Kun Dang Pharmaceutical
Phase	Phase 4
Status	COMPLETED
Enrolment	244
Start date	2008-08
Completion	2009-11

Conditions

• Dyslipidemia

Interventions

• Atorvastatin (Lipilou)
• Atorvastatin (Lipitor)

Primary outcomes

• LDL-C — after taken medicine for 8 weeks